1. FDA guidance for industry extended release oral dosage forms: development, evaluation, and application of In Vitro/In vivo correlations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 1997.
2. European Medicines Agency, EMA/CPMP/EWP/280/96 Corr1, Guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms, 2015.
3. Examining the use of a mechanistic model to generate an In vivo/In vitro correlation: Journey through a thought process;Mistry;AAPS J.,2016
4. Deconvolution and IVIVC: Exploring the role of rate-limiting conditions;Margolskee;AAPS J.,2015
5. Percent absorbed time plots derived from blood level and/or urinary excretion data;Wagner;J. Pharm. Sci.,1963